Clinical Trial Update: BAY 59-8862 in Treating Patients With Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update on BAY 59-8862 for advanced kidney cancer; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• BAY 59-8862

Snippet

Sponsor: Theradex | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN